Copyright
©2013 Baishideng Publishing Group Co.
World J Hepatol. Mar 27, 2013; 5(3): 114-119
Published online Mar 27, 2013. doi: 10.4254/wjh.v5.i3.114
Published online Mar 27, 2013. doi: 10.4254/wjh.v5.i3.114
Table 1 Patients’ baseline demographics
| Patients (n) | 35 |
| Female | 18/35 (51.4) |
| Age (yr), mean ± SD | 69 ± 13 |
| Tumor type | |
| Cholangiocarcinoma | 10/35 (28.5) |
| Hepatocellular carcinoma | 9/35 (25.7) |
| Pancreatic carcinoma | 5/35 (14.3) |
| Gastric cancer | 2/35 (5.7) |
| Bile duct cancer | 2/35 (5.7) |
| Colorectal cancer | 2/35 (5.7) |
| Gallbladder carcinoma | 2/35 (5.7) |
| Lung cancer | 1/35 (2.8) |
| Breast cancer | 1/35 (2.8) |
| Non-Hodgkin lymphoma | 1/35 (2.8) |
- Citation: Karnabatidis D, Spiliopoulos S, Katsakiori P, Romanos O, Katsanos K, Siablis D. Percutaneous trans-hepatic bilateral biliary stenting in Bismuth IV malignant obstruction. World J Hepatol 2013; 5(3): 114-119
- URL: https://www.wjgnet.com/1948-5182/full/v5/i3/114.htm
- DOI: https://dx.doi.org/10.4254/wjh.v5.i3.114